AR and prostate cancer: A Venn diagram analysis comparing these 27 targets with the 1360 prostate cancer-related targets revealed that 9 targets were shared between the active components of C. alatavicus and prostate cancer: KLK3, TP53, CCND1, EPHB2, AR, CDH1, PIK3CA, SRD5A1, and CTNNB1.